Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Eva M. Vasquez"'
Autor:
Stacy S. Shord, Robert E. Molokie, Joseph R. Camp, Charles L. Baum, Hyunyoung Jeong, Eva M. Vasquez, Hui Xie, Lingtak Neander Chan
Publikováno v:
British Journal of Clinical Pharmacology. 69:160-166
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Clotrimazole troches are commonly used as prophylaxis for thrush that may develop in immunocompromised patients. • Conflicting data suggest that clotrimazole may induce or inhibit cytochrome P450 (CYP) 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c0752475ac0aa4f743ff8f9c2a61e8c
https://doi.org/10.1111/j.1365-2125.2009.03559.x
https://doi.org/10.1111/j.1365-2125.2009.03559.x
Publikováno v:
Clinical Transplantation. 15:253-257
Purpose: Mycophenolate mofetil (MMF) has emerged as a valuable adjunctive agent in renal transplantation. However, due to intolerable adverse effects associated with MMF use in our transplant population, we have used MMF selectively in patients at hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::860ee7589f3a8a75419b0b53393185ae
https://doi.org/10.1034/j.1399-0012.2001.150406.x
https://doi.org/10.1034/j.1399-0012.2001.150406.x
Autor:
Eva M. Vasquez, David I. Min
Publikováno v:
American Journal of Health-System Pharmacy. 56:615-621
Factors considered important by transplant pharmacists in decisions about generic product selection and in defining critical-dose drugs, as well as transplant pharmacists' attitudes about bioequivalence testing, were studied. Surveys, completed by te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0061b08ec434ed7e68ce263f4eb29969
https://doi.org/10.1093/ajhp/56.7.615
https://doi.org/10.1093/ajhp/56.7.615
Autor:
Gary Barone, Timothy L. Pruett, Jon B. Klein, Cheng Tao Chang, Mark D. Pescovitz, Thomas Waid, Duane G. Wombolt, M. Gerry Choc, David I. Min, R. Wong, James B. Stinson, Raymond Pollak, John A. Meligeni, Eva M. Vasquez, John S. Thompson, Christopher L. Marsh
Publikováno v:
Transplantation. 61:875-880
This study was a randomized, double-blind, 12-week comparison of the pharmacokinetics, safety, and tolerability of two cyclosporine (CsA) formulations, cyclosporine emulsion capsules and oral solution for microemulsion and cyclosporine, in the postop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dd52a2f1ad8265ab1553ec0933f4aa0
https://doi.org/10.1097/00007890-199603270-00005
https://doi.org/10.1097/00007890-199603270-00005
Publikováno v:
Transplantation Proceedings. 34:1730-1732
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae4fa6b9c60a1794d2fcf656f1b5f823
https://doi.org/10.1016/s0041-1345(02)03000-2
https://doi.org/10.1016/s0041-1345(02)03000-2
Autor:
Eva M. Vasquez, John S. Thompson, Raymond Pollak, Dar Shong Hwang, Thomas Waid, Judy Hyun Ju Jin, Mark D. Pescovitz, Donald E. Hricik, Duane G. Wombolt, R. Wong, Timothy L. Pruett, David I. Min, M. Gerry Choc, Gary Barone, James B. Stinson, Christopher L. Marsh, Jon B. Klein
Publikováno v:
Transplantation. 63:778-780
BACKGROUND The new microemulsion formulation of cyclosporine (CsA-ME) is more bioavailable than cyclosporine (CsA) in de novo renal transplant patients. Therefore, it was of interest to compare the safety profile of each formulation in such patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ec0a7047f92b225fae44115c3bf8607
https://doi.org/10.1097/00007890-199703150-00027
https://doi.org/10.1097/00007890-199703150-00027
Publikováno v:
Therapeutic drug monitoring. 27(5)
The purpose of this pharmacokinetic study was to determine whether the relative oral bioavailability of tacrolimus is increased with concomitant administration of clotrimazole. Pharmacokinetic studies were conducted in 6 adult kidney transplant patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38b8df85f43d9c6c38c259dcf8fede80
https://pubmed.ncbi.nlm.nih.gov/16175131
https://pubmed.ncbi.nlm.nih.gov/16175131
Autor:
Howard Sankary, Enrico Benedetti, Eva M. Vasquez, N.M. Sifontis, Y Petrenko, Giuliano Testa, V Jacobssen
Publikováno v:
Transplantation proceedings. 37(1)
P-glycoprotein (P-gp) is involved in the transport of the xenobiotic immunosuppressive agents and many cytokines, such as IL-2 and IFN-gamma. Hence, P-gp activity on peripheral blood lymphocytes (PBLs) could affect the pharmacologic response to xenob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b381c2c40bd2175b9f7dfadd8eda910
https://pubmed.ncbi.nlm.nih.gov/15808585
https://pubmed.ncbi.nlm.nih.gov/15808585
Autor:
Raymond Pollak, Eva M. Vasquez
Publikováno v:
Transplantation. 62:1026-1028
Erythropoietin (EPO) is widely used among patients with end-stage renal disease awaiting transplantation. Data suggest that EPO therapy may be immunomodulatory. The purpose of this study was to assess the effects of pretransplant EPO therapy on renal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1771a7d012b819c5847c113d29d0530
https://doi.org/10.1097/00007890-199610150-00024
https://doi.org/10.1097/00007890-199610150-00024
Autor:
John S. Thompson, Donald E. Hricik, C. Martin Bunke, Mark D. Pescovitz, Raymond Pollak, M. Gerry Choc, David I. Min, Eva M. Vasquez, James B. Stinson, Judy Hyun Ju Jin, Jon B. Klein, Christopher L. Marsh, R. Wong, Duane G. Wombolt, Thomas Waid, Timothy L. Pruett, Gary Barone
Publikováno v:
Transplantation. 61:968-970
A 12-week, randomized, double-blind, multicenter pharmacokinetic study was conducted to compare the clinical safety and tolerability of cyclosporine capsules and oral solution for microemulsion and cyclosporine in 101 primary renal transplant recipie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd587d4e00d5b1c0cc8472d76f3a768b
https://doi.org/10.1097/00007890-199603270-00021
https://doi.org/10.1097/00007890-199603270-00021